Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients: A Randomised, Placebo Controlled, Double Blind Phase II Trial: NMSG #13/03

NCT00382694 is registered in ClinicalTrials.gov with Nordic Myeloma Study Group as lead sponsor.

NCT NCT00382694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00382694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients: A Randomised, Placebo Controlled, Double Blind Phase II Trial: NMSG #13/03
Lead sponsor
Nordic Myeloma Study Group
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2005
Completion date
December 31, 2006
Enrollment
80
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma